Skip to main content
Erschienen in: Journal of General Internal Medicine 11/2016

13.07.2016 | Original Research

Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System

verfasst von: Shivan J. Mehta, MD MBA MSHP, Christopher D. Jensen, PhD MPH, Virginia P. Quinn, PhD MPH, Joanne E. Schottinger, MD, Ann G. Zauber, PhD, Reinier Meester, MS, Adeyinka O. Laiyemo, MD MPH, Stacey Fedewa, MPH, Michael Goodman, MD MPH, Robert H. Fletcher, MD MSc, Theodore R. Levin, MD, Douglas A. Corley, MD PhD, Chyke A. Doubeni, MD MPH

Erschienen in: Journal of General Internal Medicine | Ausgabe 11/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Screening outreach programs using population health management principles offer services uniformly to all eligible persons, but racial/ethnic colorectal cancer (CRC) screening patterns in such programs are not well known.

Objective

To examine the association between race/ethnicity and the receipt of CRC screening and timely follow-up of positive results before and after implementation of a screening program.

Design

Retrospective cohort study of screen-eligible individuals at the Kaiser Permanente Northern California community-based integrated healthcare delivery system (2004–2013).

Subjects

A total of 868,934 screen-eligible individuals 51–74 years of age at cohort entry, which included 662,872 persons in the period before program implementation (2004–2006), 654,633 during the first 3 years after implementation (2007–2009), and 665,268 in the period from 4 to 7 years (2010–2013) after program implementation.

Intervention

A comprehensive system-wide long-term effort to increase CRC that included leadership alignment, goal-setting, and quality assurance through a PHM approach, using mailed fecal immunochemical testing (FIT) along with offering screening at office visits.

Main Measures

Differences over time and by race/ethnicity in up-to-date CRC screening (overall and by test type) and timely follow-up of a positive screen. Race/ethnicity categories included non-Hispanic white, non-Hispanic black, Hispanic/Latino, Asian/Pacific Islander, Native American, and multiple races.

Key Results

From 2004 to 2013, age/sex-adjusted CRC screening rates increased in all groups, including 35.2 to 81.1 % among whites and 35.6 to 78.0 % among blacks. Screening rates among Hispanics (33.1 to 78.3 %) and Native Americans (29.4 to 74.5 %) remained lower than those for whites both before and after program implementation. Blacks, who had slightly higher rates before program implementation (adjusted rate ratio [RR] = 1.04, 99 % CI: 1.02–1.05), had lower rates after program implementation (RR for period from 4 to 7 years = 0.97, 99 % CI: 0.96–0.97). There were also substantial improvements in timely follow-up of positive screening results.

Conclusions

In this screening program using core PHM principles, CRC screening increased markedly in all racial/ethnic groups, but disparities persisted for some groups and developed in others, which correlated with levels of adoption of mailed FIT.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Doubeni CA, Corley DA, Zauber AG. Colorectal cancer health disparities and the role of US law and health policy. Gastroenterology. 2016;150(5):1052–5.CrossRefPubMed Doubeni CA, Corley DA, Zauber AG. Colorectal cancer health disparities and the role of US law and health policy. Gastroenterology. 2016;150(5):1052–5.CrossRefPubMed
2.
Zurück zum Zitat Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol. 2008;103(6):1541–9.CrossRefPubMed Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol. 2008;103(6):1541–9.CrossRefPubMed
3.
Zurück zum Zitat Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010;375(9726):1624–33.CrossRefPubMed Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010;375(9726):1624–33.CrossRefPubMed
4.
Zurück zum Zitat Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med. 2012;366(25):2345–57.CrossRefPubMedPubMedCentral Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med. 2012;366(25):2345–57.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Doubeni CA, Weinmann S, Adams K, Kamineni A, Buist DS, Ash AS, et al. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case–control study. Ann Intern Med. 2013;158(5 Pt 1):312–20.CrossRefPubMedPubMedCentral Doubeni CA, Weinmann S, Adams K, Kamineni A, Buist DS, Ash AS, et al. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case–control study. Ann Intern Med. 2013;158(5 Pt 1):312–20.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Nishihara R, Wu K, Lochhead P, Morikawa T, Liao X, Qian ZR, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med. 2013;369(12):1095–105.CrossRefPubMed Nishihara R, Wu K, Lochhead P, Morikawa T, Liao X, Qian ZR, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med. 2013;369(12):1095–105.CrossRefPubMed
7.
Zurück zum Zitat U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(9):627–37. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(9):627–37.
8.
Zurück zum Zitat Fedewa SA, Goodman M, Flanders WD, Han X, Smith RA, Ward ME, et al. Elimination of cost-sharing and receipt of screening for colorectal and breast cancer. Cancer. 2015;121(18):3272–80.CrossRefPubMed Fedewa SA, Goodman M, Flanders WD, Han X, Smith RA, Ward ME, et al. Elimination of cost-sharing and receipt of screening for colorectal and breast cancer. Cancer. 2015;121(18):3272–80.CrossRefPubMed
10.
Zurück zum Zitat Meester RG, Doubeni CA, Zauber AG, Goede SL, Levin TR, Corley DA, et al. Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer. 2015. Meester RG, Doubeni CA, Zauber AG, Goede SL, Levin TR, Corley DA, et al. Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer. 2015.
11.
Zurück zum Zitat Robbins AS, Siegel RL, Jemal A. Racial disparities in stage-specific colorectal cancer mortality rates from 1985 to 2008. J Clin Oncol Off J Am Soc Clin Oncol. 2012;30(4):401–5.CrossRef Robbins AS, Siegel RL, Jemal A. Racial disparities in stage-specific colorectal cancer mortality rates from 1985 to 2008. J Clin Oncol Off J Am Soc Clin Oncol. 2012;30(4):401–5.CrossRef
12.
Zurück zum Zitat Soneji S, Iyer SS, Armstrong K, Asch DA. Racial disparities in stage-specific colorectal cancer mortality: 1960–2005. Am J Public Health. 2010;100(10):1912–6.CrossRefPubMedPubMedCentral Soneji S, Iyer SS, Armstrong K, Asch DA. Racial disparities in stage-specific colorectal cancer mortality: 1960–2005. Am J Public Health. 2010;100(10):1912–6.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Cooper GS, Koroukian SM. Racial disparities in the use of and indications for colorectal procedures in Medicare beneficiaries. Cancer. 2004;100(2):418–24.CrossRefPubMed Cooper GS, Koroukian SM. Racial disparities in the use of and indications for colorectal procedures in Medicare beneficiaries. Cancer. 2004;100(2):418–24.CrossRefPubMed
14.
Zurück zum Zitat Doubeni CA, Laiyemo AO, Reed G, Field TS, Fletcher RH. Socioeconomic and racial patterns of colorectal cancer screening among Medicare enrollees in 2000 to 2005. Cancer Epidemiol Biomark Prev. 2009;18(8):2170–5.CrossRef Doubeni CA, Laiyemo AO, Reed G, Field TS, Fletcher RH. Socioeconomic and racial patterns of colorectal cancer screening among Medicare enrollees in 2000 to 2005. Cancer Epidemiol Biomark Prev. 2009;18(8):2170–5.CrossRef
15.
Zurück zum Zitat Laiyemo AO, Doubeni C, Pinsky PF, Doria-Rose VP, Bresalier R, Lamerato LE, et al. Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities. J Natl Cancer Inst. 2010;102(8):538–46.CrossRefPubMedPubMedCentral Laiyemo AO, Doubeni C, Pinsky PF, Doria-Rose VP, Bresalier R, Lamerato LE, et al. Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities. J Natl Cancer Inst. 2010;102(8):538–46.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Samuel CA, Landrum MB, McNeil BJ, Bozeman SR, Williams CD, Keating NL. Racial disparities in cancer care in the Veterans Affairs health care system and the role of site of care. Am J Public Health. 2014;104(Suppl 4):S562–71.CrossRefPubMedPubMedCentral Samuel CA, Landrum MB, McNeil BJ, Bozeman SR, Williams CD, Keating NL. Racial disparities in cancer care in the Veterans Affairs health care system and the role of site of care. Am J Public Health. 2014;104(Suppl 4):S562–71.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):104–17.CrossRefPubMed Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):104–17.CrossRefPubMed
18.
Zurück zum Zitat Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975–2013, National Cancer Institute. Bethesda, MD, based on November 2015 SEER data submission, posted to the SEER web site, April 2016. Available at: http://seer.cancer.gov/csr/1975_2013/. Accessed 14 June 2016. Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975–2013, National Cancer Institute. Bethesda, MD, based on November 2015 SEER data submission, posted to the SEER web site, April 2016. Available at: http://​seer.​cancer.​gov/​csr/​1975_​2013/​.​ Accessed 14 June 2016.
19.
Zurück zum Zitat Klabunde CN, Schenck AP, Davis WW. Barriers to colorectal cancer screening among Medicare consumers. Am J Prev Med. 2006;30(4):313–9.CrossRefPubMed Klabunde CN, Schenck AP, Davis WW. Barriers to colorectal cancer screening among Medicare consumers. Am J Prev Med. 2006;30(4):313–9.CrossRefPubMed
20.
Zurück zum Zitat Wee CC, McCarthy EP, Phillips RS. Factors associated with colon cancer screening: the role of patient factors and physician counseling. Prev Med. 2005;41(1):23–9.CrossRefPubMed Wee CC, McCarthy EP, Phillips RS. Factors associated with colon cancer screening: the role of patient factors and physician counseling. Prev Med. 2005;41(1):23–9.CrossRefPubMed
21.
Zurück zum Zitat Stimpson JP, Pagan JA, Chen LW. Reducing racial and ethnic disparities in colorectal cancer screening is likely to require more than access to care. Health Aff (Millwood). 2012;31(12):2747–54.CrossRef Stimpson JP, Pagan JA, Chen LW. Reducing racial and ethnic disparities in colorectal cancer screening is likely to require more than access to care. Health Aff (Millwood). 2012;31(12):2747–54.CrossRef
22.
Zurück zum Zitat Liss DT, Baker DW. Understanding current racial/ethnic disparities in colorectal cancer screening in the United States: the contribution of socioeconomic status and access to care. Am J Prev Med. 2014;46(3):228–36.CrossRefPubMed Liss DT, Baker DW. Understanding current racial/ethnic disparities in colorectal cancer screening in the United States: the contribution of socioeconomic status and access to care. Am J Prev Med. 2014;46(3):228–36.CrossRefPubMed
23.
Zurück zum Zitat Soneji S, Armstrong K, Asch DA. Socioeconomic and physician supply determinants of racial disparities in colorectal cancer screening. J Oncol Pract. 2012;8(5):e125–34.CrossRefPubMedPubMedCentral Soneji S, Armstrong K, Asch DA. Socioeconomic and physician supply determinants of racial disparities in colorectal cancer screening. J Oncol Pract. 2012;8(5):e125–34.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Levin TR, Jamieson L, Burley DA, Reyes J, Oehrli M, Caldwell C. Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev. 2011;33(1):101–10.CrossRefPubMed Levin TR, Jamieson L, Burley DA, Reyes J, Oehrli M, Caldwell C. Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev. 2011;33(1):101–10.CrossRefPubMed
25.
Zurück zum Zitat Miles A, Cockburn J, Smith RA, Wardle J. A perspective from countries using organized screening programs. Cancer. 2004;101(5 Suppl):1201–13.CrossRefPubMed Miles A, Cockburn J, Smith RA, Wardle J. A perspective from countries using organized screening programs. Cancer. 2004;101(5 Suppl):1201–13.CrossRefPubMed
26.
Zurück zum Zitat Madlensky L, Goel V, Polzer J, Ashbury FD. Assessing the evidence for organised cancer screening programmes. Eur J Cancer. 2003;39(12):1648–53.CrossRefPubMed Madlensky L, Goel V, Polzer J, Ashbury FD. Assessing the evidence for organised cancer screening programmes. Eur J Cancer. 2003;39(12):1648–53.CrossRefPubMed
27.
Zurück zum Zitat Ioannou GN, Chapko MK, Dominitz JA. Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol. 2003;98(9):2082–91.CrossRefPubMed Ioannou GN, Chapko MK, Dominitz JA. Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol. 2003;98(9):2082–91.CrossRefPubMed
28.
Zurück zum Zitat Rhoads KF, Patel MI, Ma Y, Schmidt LA. How do integrated health care systems address racial and ethnic disparities in colon cancer? J Clin Oncol. 2015;33(8):854–60.CrossRefPubMedPubMedCentral Rhoads KF, Patel MI, Ma Y, Schmidt LA. How do integrated health care systems address racial and ethnic disparities in colon cancer? J Clin Oncol. 2015;33(8):854–60.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat von Wagner C, Baio G, Raine R, Snowball J, Morris S, Atkin W, et al. Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. Int J Epidemiol. 2011;40(3):712–8.CrossRef von Wagner C, Baio G, Raine R, Snowball J, Morris S, Atkin W, et al. Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. Int J Epidemiol. 2011;40(3):712–8.CrossRef
30.
Zurück zum Zitat Tiro JA, Kamineni A, Levin TR, Zheng Y, Schottinger JS, Rutter CM, et al. The colorectal cancer screening process in community settings: a conceptual model for the population-based research optimizing screening through personalized regimens consortium. Cancer Epidemiol Biomark Prev. 2014;23(7):1147–58.CrossRef Tiro JA, Kamineni A, Levin TR, Zheng Y, Schottinger JS, Rutter CM, et al. The colorectal cancer screening process in community settings: a conceptual model for the population-based research optimizing screening through personalized regimens consortium. Cancer Epidemiol Biomark Prev. 2014;23(7):1147–58.CrossRef
31.
Zurück zum Zitat Doubeni CA, Field TS, Buist DS, Korner EJ, Bigelow C, Lamerato L, et al. Racial differences in tumor stage and survival for colorectal cancer in an insured population. Cancer. 2007;109(3):612–20.CrossRefPubMed Doubeni CA, Field TS, Buist DS, Korner EJ, Bigelow C, Lamerato L, et al. Racial differences in tumor stage and survival for colorectal cancer in an insured population. Cancer. 2007;109(3):612–20.CrossRefPubMed
32.
Zurück zum Zitat Palitz AM, Selby JV, Grossman S, Finkler LJ, Bevc M, Kehr C, et al. The Colon Cancer Prevention Program (CoCaP): rationale, implementation, and preliminary results. HMO Pract. 1997;11(1):5–12.PubMed Palitz AM, Selby JV, Grossman S, Finkler LJ, Bevc M, Kehr C, et al. The Colon Cancer Prevention Program (CoCaP): rationale, implementation, and preliminary results. HMO Pract. 1997;11(1):5–12.PubMed
33.
Zurück zum Zitat Benson VS, Patnick J, Davies AK, Nadel MR, Smith RA, Atkin WS. Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer. 2008;122(6):1357–67.CrossRefPubMed Benson VS, Patnick J, Davies AK, Nadel MR, Smith RA, Atkin WS. Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer. 2008;122(6):1357–67.CrossRefPubMed
36.
Zurück zum Zitat van Roon AH, Goede SL, van Ballegooijen M, van Vuuren AJ, Looman CW, Biermann K, et al. Random comparison of repeated faecal immunochemical testing at different intervals for population-based colorectal cancer screening. Gut. 2013;62(3):409–15.CrossRefPubMed van Roon AH, Goede SL, van Ballegooijen M, van Vuuren AJ, Looman CW, Biermann K, et al. Random comparison of repeated faecal immunochemical testing at different intervals for population-based colorectal cancer screening. Gut. 2013;62(3):409–15.CrossRefPubMed
37.
Zurück zum Zitat Partin MR, Powell AA, Nugent S, Ordin DL. Colorectal cancer diagnosis improvement project evaluation demonstrates the importance of using multiple measures to track progress toward timeliness goals. J Healthc Qual. 2013;35(3):41–8.CrossRefPubMed Partin MR, Powell AA, Nugent S, Ordin DL. Colorectal cancer diagnosis improvement project evaluation demonstrates the importance of using multiple measures to track progress toward timeliness goals. J Healthc Qual. 2013;35(3):41–8.CrossRefPubMed
38.
Zurück zum Zitat Partin MR, Burgess DJ, Burgess JF Jr, Gravely A, Haggstrom D, Lillie SE, et al. Organizational predictors of colonoscopy follow-up for positive fecal occult blood test results: an observational study. Cancer Epidemiol Biomark Prev. 2015;24(2):422–34.CrossRef Partin MR, Burgess DJ, Burgess JF Jr, Gravely A, Haggstrom D, Lillie SE, et al. Organizational predictors of colonoscopy follow-up for positive fecal occult blood test results: an observational study. Cancer Epidemiol Biomark Prev. 2015;24(2):422–34.CrossRef
39.
Zurück zum Zitat Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–9.CrossRefPubMed Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–9.CrossRefPubMed
40.
Zurück zum Zitat Doubeni CA, Jambaulikar GD, Fouayzi H, Robinson SB, Gunter MJ, Field TS, et al. Neighborhood socioeconomic status and use of colonoscopy in an insured population--a retrospective cohort study. PLoS ONE. 2012;7(5):e36392.CrossRefPubMedPubMedCentral Doubeni CA, Jambaulikar GD, Fouayzi H, Robinson SB, Gunter MJ, Field TS, et al. Neighborhood socioeconomic status and use of colonoscopy in an insured population--a retrospective cohort study. PLoS ONE. 2012;7(5):e36392.CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Baker DW, Brown T, Buchanan DR, et al. Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial. JAMA Intern Med. 2014;174(8):1235–41.CrossRefPubMed Baker DW, Brown T, Buchanan DR, et al. Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial. JAMA Intern Med. 2014;174(8):1235–41.CrossRefPubMed
42.
43.
Zurück zum Zitat Groeneveld PW, Sonnad SS, Lee AK, Asch DA, Shea JE. Racial differences in attitudes toward innovative medical technology. J Gen Intern Med. 2006;21(6):559–63.CrossRefPubMedPubMedCentral Groeneveld PW, Sonnad SS, Lee AK, Asch DA, Shea JE. Racial differences in attitudes toward innovative medical technology. J Gen Intern Med. 2006;21(6):559–63.CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Percac-Lima S, Grant RW, Green AR, Ashburner JM, Gamba G, Oo S, et al. A culturally tailored navigator program for colorectal cancer screening in a community health center: a randomized, controlled trial. J Gen Intern Med. 2009;24(2):211–7.CrossRefPubMed Percac-Lima S, Grant RW, Green AR, Ashburner JM, Gamba G, Oo S, et al. A culturally tailored navigator program for colorectal cancer screening in a community health center: a randomized, controlled trial. J Gen Intern Med. 2009;24(2):211–7.CrossRefPubMed
45.
Zurück zum Zitat Lasser KE, Murillo J, Lisboa S, et al. Colorectal cancer screening among ethnically diverse, low-income patients: a randomized controlled trial. Arch Intern Med. 2011;171(10):906–12.CrossRefPubMed Lasser KE, Murillo J, Lisboa S, et al. Colorectal cancer screening among ethnically diverse, low-income patients: a randomized controlled trial. Arch Intern Med. 2011;171(10):906–12.CrossRefPubMed
46.
Zurück zum Zitat Walsh JM, Salazar R, Nguyen TT, Kaplan C, Nguyen L, Hwang J, et al. Healthy colon, healthy life: a novel colorectal cancer screening intervention. Am J Prev Med. 2010;39(1):1–14.CrossRefPubMedPubMedCentral Walsh JM, Salazar R, Nguyen TT, Kaplan C, Nguyen L, Hwang J, et al. Healthy colon, healthy life: a novel colorectal cancer screening intervention. Am J Prev Med. 2010;39(1):1–14.CrossRefPubMedPubMedCentral
47.
Zurück zum Zitat Doubeni CA. The impact of colorectal cancer screening on the US population: is it time to celebrate? Cancer. 2014;120(18):2810–3.CrossRefPubMed Doubeni CA. The impact of colorectal cancer screening on the US population: is it time to celebrate? Cancer. 2014;120(18):2810–3.CrossRefPubMed
Metadaten
Titel
Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System
verfasst von
Shivan J. Mehta, MD MBA MSHP
Christopher D. Jensen, PhD MPH
Virginia P. Quinn, PhD MPH
Joanne E. Schottinger, MD
Ann G. Zauber, PhD
Reinier Meester, MS
Adeyinka O. Laiyemo, MD MPH
Stacey Fedewa, MPH
Michael Goodman, MD MPH
Robert H. Fletcher, MD MSc
Theodore R. Levin, MD
Douglas A. Corley, MD PhD
Chyke A. Doubeni, MD MPH
Publikationsdatum
13.07.2016
Verlag
Springer US
Erschienen in
Journal of General Internal Medicine / Ausgabe 11/2016
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-016-3792-1

Weitere Artikel der Ausgabe 11/2016

Journal of General Internal Medicine 11/2016 Zur Ausgabe

Clinical Practice: Clinical Images

Omphalolith: An Umbilical Concretion to Recognize

Clinical Practice: Clinical Images

More than Meets the Eye: Metastatic Uveal Melanoma

Letter to the Editor

Vitamin D: Ten Beliefs

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.